Alvotech Strikes $45m Deal With Yas Holding

Biosimilars Deal Includes 2.5% Stake And MENA Rights

 
• By David Wallace
  
Syringe
The deal gives Alvotech another injection of cash following Fuji Pharma’s $50m investment announced last year • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Deals

More from Business